Viral RNA biomarker for the prediction of mortality from COVID-19

A team of researchers from the Université de Montréal (Montréal, Canada) report on the potential discovery of a blood biomarker for SARS-CoV-2 that may identify patients most at risk of dying from COVID-19. Throughout the COVID-19 pandemic, great effort has been made to curb the spread and severity of the effects of the SARS-CoV-2 virus. These efforts have resulted in the development of various detection methods, therapeutics and vaccines. However, the prediction and measuring of disease severity has remained less of a focus, with no current method or technology in place to predict the severity of disease progression in an individual.   In order to investigate...